Drug Trial Radar · NCT07633119
A Phase Ⅲ Clinical Study of SNA02-48 Injection
Last checked: Nov 19, 2026Latest source record: Jun 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
600
Planned (sponsor's estimate)
Start
Jun 28, 2026
Primary completion
Mar 31, 2027
Study completion May 31, 2027
Sponsor
- Lead sponsor
- Sinovac Life Sciences Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jun 8, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this clinical trial is to compare the efficacy and safety of SNA02-48 injection with Human Tetanus Immunoglobulin (HTIG) for tetanus prophylaxis.
Conditions
- Tetanus
Interventions
SNA02-48Drug
IM gluteal injection
Human tetanus immunoglobulin (HTIG)Drug
IM gluteal injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- The proportion of participants with an increase of anti-tetanus neutralizing antibody titers (∆ titers) over protective level.Time frame: Baseline up to 12 hours after receipt of study drug
Locations
30 sites in 1 country. Site status is shown where the registry gives one.
Taihe County People's Hospital
Fuyang, Anhui, China
The Second Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
Peking University First Hospital
Beijing, Beijing Municipality, China
Peking University People's Hospital
Beijing, Beijing Municipality, China
Beijing Tiantan Hospital Affiliated to Capital Medical University
Beijing, Beijing Municipality, China
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
The Third Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
Guangzhou Eighth People's Hospital, Guangzhou Medical University
Guangzhou, Guangdong, China
The Fifth Affiliated Hospital of Southern Medical University
Guangzhou, Guangdong, China
Shenzhen Second People's Hospital
Shenzhen, Guangdong, China
Longhua District People's Hospital of Shenzhen
Shenzhen, Guangdong, China
Liuzhou Worker's Hospital
Liuzhou, Guangxi, China
Liuzhou People's Hospital
Liuzhou, Guangxi, China
Affiliated Hospital of Zunyi Medical University
Zunyi, Guizhou, China
The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Wuhan Union Hospital
Wuhan, Hubei, China
Affiliated Nanhua Hospital, University of South China
Hengyang, Hunan, China
Taizhou People's Hospital
Taizhou, Jiangsu, China
Affiliated Hospital of Yangzhou University
Yangzhou, Jiangsu, China
Affiliated Hospital of Jiangsu University
Zhenjiang, Jiangsu, China
The Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Pingxiang People's Hospital
Pingxiang, Jiangxi, China
Weifang People's Hospital
Weifang, Shandong, China
Linfen Central Hospital
Linfen, Shanxi, China
Shanxi Bethune Hospital
Taiyuan, Shanxi, China
Yuncheng Central Hospital, Shanxi Province
Yuncheng, Shanxi, China
West China Hospital, Sichuan University
Chengdu, Sichuan, China
Lishui Central Hospital
Lishui, Zhejiang, China
Ningbo Medical Center Li Huili Hospital
Ningbo, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.